Anteris Technologies (ASX:AVR) logged a $0.30 loss per share for the second quarter, compared with a $0.58 loss per share a year ago, a Wednesday filing showed.
For the three months ended June 30, net sales reached $1 million versus $618,000 previously, the Australia-listed medical technology company added.